Title:

Associate Director,
Slone Epidemiology Center

Professor of Epidemiology,
Boston University School of Public Health

Education:

M.S., Chemistry, 1965, Boston University
M.S., Biostatistics, 1972, Harvard School of Public Health
Sc.D., Epidemiology, 1978, Harvard School of Public Health

Research Interests:

Lynn Rosenberg is professor of epidemiology at Boston University School of Public Health. She received her M.S. in chemistry from Boston University and M.S. in biostatistics and Sc.D. in epidemiology from Harvard University. Dr. Rosenberg’s research has been in the areas of cancer epidemiology, cardiovascular epidemiology, and drug epidemiology, with a recent emphasis on women’s health. She has carried out multiple studies of risk factors for cancers, including cancer of the breast, cervix, and colon, and for myocardial infarction. Particular interests have been the health effects of oral and injectable contraceptives and of noncontraceptive estrogens. Several important hypotheses have been raised by her studies: that alcohol consumption increases the incidence of breast cancer and that use of nonsteroidal anti-inflammatory drugs decreases the incidence of large bowel cancer. Both hypotheses were subsequently confirmed in numerous studies. Currently, she is PI of the long-running Case-Control Surveillance Study, which has been in progress since 1975; multiple case-control studies are conducted within the same administrative framework to assess the unanticipated effects of medications on the incidence of various cancers. She heads a cross-sectional study of the effect of injectable progestin contraceptives on bone mineral density in African women and women of mixed race in South Africa . She is also PI of the Black Women’s Health Study, the largest follow-up study of the health of African-American women yet conducted. The study, conducted in collaboration with investigators at Howard University, follows 59,000 black women from across the U.S. to assess risk factors for outcomes that include breast cancer, other cancers, hypertension, diabetes, systemic lupus erythematosus, uterine fibroids, and preterm birth. Dr. Rosenberg is the author of over 200 scientific papers.